|
Kabra Drugs Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
46.09 Cr.
|
P/BV
|
1.87
|
Book Value (Rs.)
|
10.40
|
|
52 Week High/Low (Rs.)
|
23/10
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -0.99 | -1.66 | -0.77 | -0.42 | -0.41 |
| Diluted EPS (Rs.) | -0.99 | -1.66 | -0.77 | -0.42 | -0.41 |
| Cash EPS (Rs.) | -0.45 | -1.68 | -0.76 | -0.39 | -0.33 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 10.40 | -3.34 | -1.67 | -0.89 | -0.47 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 10.40 | -3.34 | -1.67 | -0.89 | -0.47 |
| PBDIT / Share (Rs.) | -0.45 | -1.68 | -0.76 | -0.39 | -0.33 |
| PBIT / Share (Rs.) | -0.45 | -1.68 | -0.76 | -0.42 | -0.41 |
| PBT / Share (Rs.) | -0.45 | -1.68 | -0.76 | -0.42 | -0.41 |
| Net Profit / Share (Rs.) | -0.45 | -1.68 | -0.76 | -0.42 | -0.41 |
| Return on Networth / Equity (%) | -4.40 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Capital Employeed (%) | -4.40 | -67.97 | 46.22 | 47.15 | 86.65 |
| Return On Assets (%) | -4.30 | -16.10 | -48.02 | -25.40 | -12.83 |
| Total Debt / Equity (X) | 0.01 | -1.16 | -1.89 | -2.61 | -4.33 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 43.84 | 1.30 | 0.47 | 0.62 | 0.85 |
| Quick Ratio (X) | 43.84 | 1.30 | 0.47 | 0.62 | 0.85 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 5.41 | 2.19 | 3.82 | 3.02 | 2.87 |
| EV / EBITDA (X) | -5.02 | -2.98 | -11.32 | -17.22 | -19.29 |
| Price / BV (X) | 1.07 | -2.15 | -3.35 | -5.08 | -9.53 |
| EarningsYield | -0.04 | -0.23 | -0.13 | -0.09 | -0.09 |
